Page last updated: 2024-08-23

dermatan sulfate and Hypertension, Portal

dermatan sulfate has been researched along with Hypertension, Portal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akuta, N; Arase, Y; Fujiyama, S; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y	1
Akahoshi, T; Harimoto, N; Iguchi, T; Itoh, S; Kawanaka, H; Maehara, Y; Shirabe, K; Takenaka, K; Uchiyama, H; Yoshizumi, T	1
Kokubu, S	1

Reviews

1 review(s) available for dermatan sulfate and Hypertension, Portal

Article	Year
[Diagnosis, pathogenesis and latest therapy in portal hypertension]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2008, Volume: 105, Issue:11 Topics: Angiotensin II Type 1 Receptor Blockers; Antithrombin III; Balloon Occlusion; Chondroitin Sulfates; Dermatan Sulfate; Drug Therapy, Combination; Embolization, Therapeutic; Fibrinolytic Agents; Heparitin Sulfate; Humans; Hypertension, Portal; Splenic Artery	2008

Article

Year

[Diagnosis, pathogenesis and latest therapy in portal hypertension].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2008, Volume: 105, Issue:11

Topics: Angiotensin II Type 1 Receptor Blockers; Antithrombin III; Balloon Occlusion; Chondroitin Sulfates; Dermatan Sulfate; Drug Therapy, Combination; Embolization, Therapeutic; Fibrinolytic Agents; Heparitin Sulfate; Humans; Hypertension, Portal; Splenic Artery

2008

Trials

1 trial(s) available for dermatan sulfate and Hypertension, Portal

Article	Year
Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension. Journal of the American College of Surgeons, 2014, Volume: 219, Issue:5 Topics: Adult; Aged; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Clinical Protocols; Decision Support Techniques; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Hypertension, Portal; Laparoscopy; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Postoperative Complications; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Splenectomy; Venous Thrombosis; Warfarin	2014

Article

Year

Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.

Journal of the American College of Surgeons, 2014, Volume: 219, Issue:5

Topics: Adult; Aged; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Clinical Protocols; Decision Support Techniques; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Hypertension, Portal; Laparoscopy; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Postoperative Complications; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Splenectomy; Venous Thrombosis; Warfarin

2014

Other Studies

1 other study(ies) available for dermatan sulfate and Hypertension, Portal

Article	Year
Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. BMC gastroenterology, 2017, Oct-25, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Contrast Media; Dermatan Sulfate; Female; Heparitin Sulfate; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Recurrence; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Warfarin	2017

Article

Year

Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.

BMC gastroenterology, 2017, Oct-25, Volume: 17, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Contrast Media; Dermatan Sulfate; Female; Heparitin Sulfate; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Recurrence; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Warfarin

2017